BCTX
BriaCell Therapeutics Corp.Company with tickers: BCTX, BCTXL, BCTXZ
CIK
1610820
CUSIP
107930307
Shares Outstanding
7,250,487
13F Activity (30d)
13 filings
13 filers
Price
$3.45
Market Cap
$24.80M
P/E Ratio
-0.06
EPS (Diluted)
$-62.19
52W High
$36.90
52W Low
$2.98
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $15,854,209 | USD | 2026-01-31 | 10-Q | 2026-03-10 |
| Research & Development | $12,737,332 | USD | 2026-01-31 | 10-Q | 2026-03-10 |
| Operating Income | $-15,854,209 | USD | 2026-01-31 | 10-Q | 2026-03-10 |
| Net Income | $-15,419,385 | USD | 2026-01-31 | 10-Q | 2026-03-10 |
| EPS (Basic) | $-2.58 | USD/shares | 2026-01-31 | 10-Q | 2026-03-10 |
| EPS (Diluted) | $-6.58 | USD/shares | 2026-01-31 | 10-Q | 2026-03-10 |